Literature DB >> 19963335

A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System.

Debbie Selby1, Alisa Cascella, Kate Gardiner, Randy Do, Veronika Moravan, Jeff Myers, Edward Chow.   

Abstract

Symptom intensity in cancer and palliative care patients is frequently assessed using a 0-10 ranking score. Results are then often grouped into verbal categories (mild, moderate, or severe) to guide therapy. Numerical cutpoints separating these categories are often variable, with previous work suggesting different cutpoints across different symptoms, which is unwieldy for clinical use. The Edmonton Symptom Assessment Symptom (ESAS) assesses nine common symptoms using this 0-10 scale. The primary aim of this study was to examine the relationship between the numerical and verbal scores using the ESAS and to identify a single cutpoint to separate severe from nonsevere symptomatology. A second goal was to similarly identify a cutpoint to separate moderate or severe from none or mild symptom intensity. Consenting patients (n=400) completed both a standard ESAS and an identical form that replaced 0-10 with none, mild, moderate, and severe. Receiver operating characteristic curves were generated to identify the best fit between sensitivity and specificity. For the "severe" ranking, six symptoms had a best fit of 7, with sensitivity for the remaining three symptoms still greater than 80%. For the combined grouping of moderate or severe, results were less uniform. A cutpoint of either 4 or 5 would be supported by our data, with a greater sensitivity using 4 and improved specificity using 5 as the cutpoint. Across all ESAS symptoms, then, 7 or higher represents a severe symptom by patient definition, whereas a cutpoint of either 4 or 5 could reasonably define combined moderate and severe symptoms. Copyright 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19963335     DOI: 10.1016/j.jpainsymman.2009.06.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  53 in total

1.  Using Screening for Distress, the sixth vital sign, to advance patient care with assessment and targeted interventions.

Authors:  Amy Waller; Sheila N Garland; Barry D Bultz
Journal:  Support Care Cancer       Date:  2012-06-07       Impact factor: 3.603

2.  Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions.

Authors:  J J Koldenhof; P O Witteveen; R de Vos; M Walraven; C N Tillier; H M W Verheul; S C C M Teunissen
Journal:  Support Care Cancer       Date:  2014-04-02       Impact factor: 3.603

Review 3.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

4.  Reductions in Fatigue Predict Occupational Re-engagement in Individuals with Work-Related Musculoskeletal Disorders.

Authors:  Keiko Yamada; Heather Adams; Tamra Ellis; Robyn Clark; Craig Sully; Michael J L Sullivan
Journal:  J Occup Rehabil       Date:  2020-03

5.  Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.

Authors:  Yael Schenker; Seo Young Park; Kwonho Jeong; Jennifer Pruskowski; Dio Kavalieratos; Judith Resick; Amy Abernethy; Jean S Kutner
Journal:  J Gen Intern Med       Date:  2019-02-04       Impact factor: 5.128

6.  Potentially Avoidable Hospital Readmissions in Patients With Advanced Cancer.

Authors:  P Connor Johnson; Yian Xiao; Risa L Wong; Sara D'Arpino; Samantha M C Moran; Daniel E Lage; Brandon Temel; Margaret Ruddy; Lara N Traeger; Joseph A Greer; Ephraim P Hochberg; Jennifer S Temel; Areej El-Jawahri; Ryan D Nipp
Journal:  J Oncol Pract       Date:  2019-04-04       Impact factor: 3.840

7.  Age differences in the last week of life in advanced cancer patients followed at home.

Authors:  Sebastiano Mercadante; Federica Aielli; Francesco Masedu; Marco Valenti; Lucilla Verna; Giampiero Porzio
Journal:  Support Care Cancer       Date:  2015-10-16       Impact factor: 3.603

8.  Aerobic exercise during chemotherapy infusion for cancer treatment: a novel randomised crossover safety and feasibility trial.

Authors:  Vanessa J Thomas; Catherine Seet-Lee; Michael Marthick; Birinder S Cheema; Michael Boyer; Kate M Edwards
Journal:  Support Care Cancer       Date:  2019-05-21       Impact factor: 3.603

9.  Symptoms of posttraumatic stress disorder among hospitalized patients with cancer.

Authors:  Ryan D Nipp; Areej El-Jawahri; Sara M D'Arpino; Andy Chan; Charn-Xin Fuh; P Connor Johnson; Daniel E Lage; Risa L Wong; William F Pirl; Lara Traeger; Barbara J Cashavelly; Vicki A Jackson; David P Ryan; Ephraim P Hochberg; Jennifer S Temel; Joseph A Greer
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

10.  Weight changes correlate with alterations in subjective physical function in advanced cancer patients referred to a specialized nutrition and rehabilitation team.

Authors:  Monica P Parmar; Tara Swanson; R Thomas Jagoe
Journal:  Support Care Cancer       Date:  2013-02-26       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.